Cargando…

Prognostic features of sarcoidosis course in a Brazilian cohort

OBJECTIVE: To identify predictive features associated with the course of sarcoidosis at initial evaluation and to develop a predictive score. METHODS: This was a retrospective study involving pulmonary sarcoidosis patients, classified as having a self-limited or persistent course of disease, compari...

Descripción completa

Detalles Bibliográficos
Autores principales: Castro, Marina Dornfeld Cunha, Pereira, Carlos Alberto de Castro, Soares, Maria Raquel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Pneumologia e Tisiologia 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836631/
https://www.ncbi.nlm.nih.gov/pubmed/35137872
http://dx.doi.org/10.36416/1806-3756/e20210366
_version_ 1784649727439011840
author Castro, Marina Dornfeld Cunha
Pereira, Carlos Alberto de Castro
Soares, Maria Raquel
author_facet Castro, Marina Dornfeld Cunha
Pereira, Carlos Alberto de Castro
Soares, Maria Raquel
author_sort Castro, Marina Dornfeld Cunha
collection PubMed
description OBJECTIVE: To identify predictive features associated with the course of sarcoidosis at initial evaluation and to develop a predictive score. METHODS: This was a retrospective study involving pulmonary sarcoidosis patients, classified as having a self-limited or persistent course of disease, comparing data between the outcomes by univariate analysis. Features related to persistent disease were selected by multivariate analysis and a prognostic score was designed. RESULTS: The sample comprised 200 patients (mean age = 49 years). The median duration of symptoms to diagnosis was 12 months, and delayed diagnosis (> 12 months) was found in 43% of the cases. The most common radiological stage was II; 37% had reduced FVC. Relevant systemic involvement was detected in 37% of the patients. Treatment for tuberculosis was prescribed in 44 patients prior to sarcoidosis diagnosis. Treatment for sarcoidosis was required in 77% of the sample, and the disease course was persistent in 115 cases. Excluding 40 patients with fibrotic disease, prognostic factors to persistent disease were parenchymal involvement, delayed diagnosis, dyspnea, relevant systemic involvement, and reduced FVC. On the basis of the analysis, a 3-letter scoring system (A, B and C) was developed according to the selected factors. The positive predictive values for persistent course for A (≤ 1 point) and C scores (≥ 4 points) were 12.5% and 81.8%, respectively. CONCLUSIONS: A score can be derived by selected features at initial evaluation, allowing the prediction of outcomes in a significant number of sarcoidosis patients.
format Online
Article
Text
id pubmed-8836631
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedade Brasileira de Pneumologia e Tisiologia
record_format MEDLINE/PubMed
spelling pubmed-88366312022-03-14 Prognostic features of sarcoidosis course in a Brazilian cohort Castro, Marina Dornfeld Cunha Pereira, Carlos Alberto de Castro Soares, Maria Raquel J Bras Pneumol Original Article OBJECTIVE: To identify predictive features associated with the course of sarcoidosis at initial evaluation and to develop a predictive score. METHODS: This was a retrospective study involving pulmonary sarcoidosis patients, classified as having a self-limited or persistent course of disease, comparing data between the outcomes by univariate analysis. Features related to persistent disease were selected by multivariate analysis and a prognostic score was designed. RESULTS: The sample comprised 200 patients (mean age = 49 years). The median duration of symptoms to diagnosis was 12 months, and delayed diagnosis (> 12 months) was found in 43% of the cases. The most common radiological stage was II; 37% had reduced FVC. Relevant systemic involvement was detected in 37% of the patients. Treatment for tuberculosis was prescribed in 44 patients prior to sarcoidosis diagnosis. Treatment for sarcoidosis was required in 77% of the sample, and the disease course was persistent in 115 cases. Excluding 40 patients with fibrotic disease, prognostic factors to persistent disease were parenchymal involvement, delayed diagnosis, dyspnea, relevant systemic involvement, and reduced FVC. On the basis of the analysis, a 3-letter scoring system (A, B and C) was developed according to the selected factors. The positive predictive values for persistent course for A (≤ 1 point) and C scores (≥ 4 points) were 12.5% and 81.8%, respectively. CONCLUSIONS: A score can be derived by selected features at initial evaluation, allowing the prediction of outcomes in a significant number of sarcoidosis patients. Sociedade Brasileira de Pneumologia e Tisiologia 2022-01-24 /pmc/articles/PMC8836631/ /pubmed/35137872 http://dx.doi.org/10.36416/1806-3756/e20210366 Text en © 2022 Sociedade Brasileira de Pneumologia e Tisiologia https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Original Article
Castro, Marina Dornfeld Cunha
Pereira, Carlos Alberto de Castro
Soares, Maria Raquel
Prognostic features of sarcoidosis course in a Brazilian cohort
title Prognostic features of sarcoidosis course in a Brazilian cohort
title_full Prognostic features of sarcoidosis course in a Brazilian cohort
title_fullStr Prognostic features of sarcoidosis course in a Brazilian cohort
title_full_unstemmed Prognostic features of sarcoidosis course in a Brazilian cohort
title_short Prognostic features of sarcoidosis course in a Brazilian cohort
title_sort prognostic features of sarcoidosis course in a brazilian cohort
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836631/
https://www.ncbi.nlm.nih.gov/pubmed/35137872
http://dx.doi.org/10.36416/1806-3756/e20210366
work_keys_str_mv AT castromarinadornfeldcunha prognosticfeaturesofsarcoidosiscourseinabraziliancohort
AT pereiracarlosalbertodecastro prognosticfeaturesofsarcoidosiscourseinabraziliancohort
AT soaresmariaraquel prognosticfeaturesofsarcoidosiscourseinabraziliancohort